Nov 05, 2025 • Zacks Commentary
BULLISH
Why TG Therapeutics ( TGTX ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Nov 04, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised
TG Therapeutics beats third-quarter estimates as a surge in Briumvi sales drives revenues up 92.8% and leads to a higher 2025 outlook.
Nov 03, 2025 • Benzinga
NEUTRAL
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More - Palantir Technologies ( NASDAQ:PLTR )
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday. Here's a look at the names most likely to be on individual investors' radars. CIFR stock is soaring. Watch the real-time price action here.
Oct 31, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
Conference Call to be Held Monday, November 3, 2025, at 8:30 am ET Conference Call to be Held Monday, November 3, 2025, at 8:30 am ET ...
Oct 31, 2025 • Benzinga
SOMEWHAT-BULLISH
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update - TG Therapeutics ( NASDAQ:TGTX )
NEW YORK, Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- TG Therapeutics, Inc. ( NASDAQ:TGTX ) , today announced that a conference call will be held, Monday, November 3, 2025, at 8:30 AM ET to discuss results for the third quarter of 2025 and provide a business outlook for the remainder of 2025. Michael S.
Oct 28, 2025 • Zacks Commentary
NEUTRAL
Arcus Biosciences, Inc. ( RCUS ) Reports Q3 Loss, Beats Revenue Estimates
Arcus Biosciences (RCUS) delivered earnings and revenue surprises of +4.51% and +27.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?